The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Envoy Medical Inc (NASDAQ: COCH) was $0.85 for the day, down -9.99% from the previous closing price of $0.94. In other words, the price has decreased by -$9.99 from its previous closing price. On the day, 1.14 million shares were traded. COCH stock price reached its highest trading level at $0.9619 during the session, while it also had its lowest trading level at $0.7693.
Ratios:
Our analysis of COCH’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.94.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of. The stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on June 24, 2024, initiated with a Buy rating and assigned the stock a target price of $8.50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 11 ’25 when Patel Mona Chetan bought 2,500 shares for $1.47 per share. The transaction valued at 3,675 led to the insider holds 20,000 shares of the business.
Patel Mona Chetan bought 10,000 shares of COCH for $14,600 on Jun 06 ’25. The Director now owns 17,500 shares after completing the transaction at $1.46 per share. On May 27 ’25, another insider, BRYNELSEN CHARLES, who serves as the Director of the company, bought 35,000 shares for $1.65 each. As a result, the insider paid 57,673 and bolstered with 50,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COCH now has a Market Capitalization of 20326520 and an Enterprise Value of 41840944. For the stock, the TTM Price-to-Sale (P/S) ratio is 83.17. Its current Enterprise Value per Revenue stands at 188.473 whereas that against EBITDA is -2.151.
Stock Price History:
The Beta on a monthly basis for COCH is 2.10, which has changed by -0.7605634 over the last 52 weeks, in comparison to a change of 0.16333759 over the same period for the S&P500. Over the past 52 weeks, COCH has reached a high of $3.99, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is -38.57%, while the 200-Day Moving Average is calculated to be -42.69%.
Shares Statistics:
COCH traded an average of 293.81K shares per day over the past three months and 347300 shares per day over the past ten days. A total of 21.52M shares are outstanding, with a floating share count of 10.19M. Insiders hold about 52.64% of the company’s shares, while institutions hold 55.95% stake in the company. Shares short for COCH as of 1756425600 were 301387 with a Short Ratio of 1.03, compared to 1753920000 on 92063. Therefore, it implies a Short% of Shares Outstanding of 301387 and a Short% of Float of 2.76.
Earnings Estimates
Envoy Medical Inc (COCH) is currently under the scrutiny of 3.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.33, with high estimates of -$0.32 and low estimates of -$0.34.
Analysts are recommending an EPS of between -$1.25 and -$1.27 for the fiscal current year, implying an average EPS of -$1.26. EPS for the following year is -$1.26, with 2.0 analysts recommending between -$1.18 and -$1.34.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 2 analysts. It ranges from a high estimate of $100k to a low estimate of $60k. As of the current estimate, Envoy Medical Inc’s year-ago sales were $56kFor the next quarter, 2 analysts are estimating revenue of $80k. There is a high estimate of $100k for the next quarter, whereas the lowest estimate is $60k.
A total of 2 analysts have provided revenue estimates for COCH’s current fiscal year. The highest revenue estimate was $300k, while the lowest revenue estimate was $200k, resulting in an average revenue estimate of $250k. In the same quarter a year ago, actual revenue was $225kBased on 3 analysts’ estimates, the company’s revenue will be $300k in the next fiscal year. The high estimate is $400k and the low estimate is $200k.
